Apolipoprotein E-/- mice have delayed skeletal muscle healing after hind limb ischemia-reperfusion

Journal of Vascular Surgery

Volumn 48, Issue 3, 2008, Pages 701-708

  Kang, Jeanwan ^a   Albadawi, Hassan ^a   Patel, Virendra I ^a   Abbruzzese, Thomas A ^a   Yoo, Jin Hyung ^a   Austen Jr , W Gerald ^a   Watkins, Michael T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR2; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; MYOGENIN; OSTEOPONTIN;

ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; LEG ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVASCULARIZATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; CHEMOKINE CCL2; CHEMOKINE CXCL2; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HINDLIMB; HYPERCHOLESTEROLEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIN; OSTEOPONTIN; PEROXIDASE; RECEPTORS, CCR2; REPERFUSION INJURY; TIME FACTORS; WOUND HEALING;

EID: 49749101184     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.04.006     Document Type: Article

References (38)

1. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
2. Pasternak R.C., Criqui M.H., Benjamin E.J., Fowkes F.G., Isselbacher E.M., McCullough P.A., et al. Atherosclerotic vascular disease conference: Writing Group I: epidemiology. Circulation 109 (2004) 2605-2612
3. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., and Wilson P.W. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002) 961-965
4. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
5. Criqui M.H., Fronek A., Klauber M.R., Barrett-Connor E., and Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71 (1985) 516-522
6. Ouriel K. Peripheral arterial disease. Lancet 358 (2001) 1257-1264
7. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344 (2001) 1608-1621
8. Goshima K.R., Mills Sr. J.L., and Hughes J.D. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 39 (2004) 330-335
9. Taylor S.M., Cull D.L., Kalbaugh C.A., Cass A.L., Harmon S.A., Langan III E.M., et al. Critical analysis of clinical success after surgical bypass for lower-extremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment. J Am Coll Surg 204 (2007) 831-838
10. DeRubertis B.G., Faries P.L., McKinsey J.F., Chaer R.A., Pierce M., Karwowski J., et al. Shifting paradigms in the treatment of lower extremity vascular disease. Ann Surg 246 (2007) 415-424
11. Galaria I.I., and Davies M.G. Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions. Ann Vasc Surg 19 (2005) 1-9
12. Zadelaar S., Kleemann R., Verschuren L., de Vries-Van der Weij J., van der Hoorn J., Princen H.M., et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27 (2007) 1706-1721
13. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse: a decade in progress. Arterioscler Thromb Vasc Biol 24 (2004) 1006-1014
14. Fazio S., and Linton M.F. Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse. Circulation 111 (2005) 3349-3351
15. Curtiss LK, Boisvert WA. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 100;11:243-51.
16. Crawford R.S., Hashmi F.F., Jones J.E., Albadawi H., McCormack M., Eberlin K., et al. A novel model of acute murine hindlimb ischemia. Am J Physiol Heart Circ Physiol 292 (2007) H830-H837
17. Chan R.K., Austen Jr. W.G., Ibrahim S., Ding G.Y., Verna N., Hechtman H.B., et al. Reperfusion injury to skeletal muscle affects primarily type II muscle fibers. J Surg Res 122 (2004) 54-60
18. Paoni N.F., Peale F., Wang F., Errett-Baroncini C., Steinmetz H., Toy K., et al. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice. Physiol Genomics 11 (2002) 263-272
19. Zammit P.S., Partridge T.A., and Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 54 (2006) 1177-1191
20. Mackay C.R. Chemokine receptors and T cell chemotaxis. J Exp Med 184 (1996) 799-802
21. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 95 (2004) 858-866
22. Shireman P.K., Contreras-Shannon V., Reyes-Reyna S.M., Robinson S.C., and McManus L.M. MCP-1 parallels inflammatory and regenerative responses in ischemic muscle. J Surg Res 134 (2006) 145-157
23. Warren G.L., Hulderman T., Mishra D., Gao X., Millecchia L., O'Farrell L., et al. Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J 19 (2005) 413-415
24. Warren G.L., O'Farrell L., Summan M., Hulderman T., Mishra D., Luster M.I., et al. Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 286 (2004) 1031-1036
25. Tidball J.G. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288 (2005) R345-R353
26. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 (2004) 9S-16S
27. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
28. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
29. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108 (2003) 1772-1778
30. Schober A., Bernhagen J., Thiele M., Zeiffer U., Knarren S., Roller M., et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109 (2004) 380-385
31. De Lemos J.A., Morrow D.A., Sabatine M.S., Murphy S.A., Gibson C.M., Antman E.M., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107 (2003) 690-695
32. Yu X., Dluz S., Graves D.T., Zhang L., Antoniades H.N., Hollander W., et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci U S A 89 (1992) 6953-6957
33. Aiello R.J., Bourassa P.K., Lindsey S., Weng W., Natoli E., Rollins B.J., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19 (1999) 1518-1525
34. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2 (1998) 275-281
35. Egashira K., Zhao Q., Kataoka C., Ohtani K., Usui M., Charo I.F., et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90 (2002) 1167-1172
36. Wakai A., Winter D.C., Street J.T., O'Sullivan R.G., Wang J.H., and Redmond H.P. Inosine attenuates tourniquet-induced skeletal muscle reperfusion injury. J Surg Res 99 (2001) 311-315
37. Hua H.T., Albadawi H., Entabi F., Stoner M.C., Diamond R.E., Bonheur J.A., et al. CXC chemokine expression and synthesis in skeletal muscle during ischemia/reperfusion. J Vasc Surg 42 (2005) 337-343
38. Conrad M.F., Stone D.H., Albadawi H., Hua H.T., Entabi F., Stoner M.C., et al. Local inflammatory and thrombotic responses differ in a murine model of partial and complete hindlimb ischemia/reperfusion. Surgery 138 (2005) 375-381